We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+3.53%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.33%
AUM
$12B
AUM Growth
-$353M
Cap. Flow
-$617M
Cap. Flow %
-5.16%
Top 10 Hldgs %
12.46%
Holding
637
New
171
Increased
105
Reduced
150
Closed
191

Top Buys

Rank Stock Value
1
DAL icon
Delta Air Lines
DAL
+$140M
2
ABBV icon
AbbVie
ABBV
+$119M
3
KEY icon
KeyCorp
KEY
+$115M
4
FFIV icon
F5
FFIV
+$111M
5
WMT icon
Walmart Inc
WMT
+$110M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$146M
2
SPGI icon
S&P Global
SPGI
+$142M
3
LLY icon
Eli Lilly
LLY
+$133M
4
LH icon
Labcorp
LH
+$131M
5
RHT
Red Hat Inc
RHT
+$121M

Sector Composition

Rank Sector Weight
1 Technology 17.86%
2 Healthcare 13.19%
3 Industrials 12.91%
4 Consumer Discretionary 10.27%
5 Financials 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XENE icon
376
Xenon Pharmaceuticals
XENE
$6.22B
$1.39M 0.01%
441,260
+1,366
+0.3% +$5.34K
OAKS
377
DELISTED
Five Oaks Investment Corp.
OAKS
$1.38M 0.01%
+281,739
New +$1.48M
OKTA icon
378
Okta
OKTA
$25.6B
$1.37M 0.01%
+60,000
New +$1.48M
RGEN icon
379
Repligen
RGEN
$8.95B
$1.36M 0.01%
+32,863
New +$1.25M
UTI icon
380
Universal Technical Institute
UTI
$2.33B
$1.35M 0.01%
377,355
+54,932
+17% +$198K
NERV icon
381
Minerva Neurosciences
NERV
$203M
$1.33M 0.01%
+18,750
New +$1.21M
BOC icon
382
Boston Omaha
BOC
$438M
$1.32M 0.01%
+100,000
New +$1.33M
RF icon
383
Regions Financial
RF
$27.2B
$1.31M 0.01%
+89,186
New +$1.26M
VOYA icon
384
Voya Financial
VOYA
$9.08B
$1.29M 0.01%
34,983
-747,340
-96% -$27.2M
WAL icon
385
Western Alliance Bancorporation
WAL
$9.05B
$1.29M 0.01%
26,224
-1,096,416
-98% -$52.2M
EVH icon
386
Evolent Health
EVH
$346M
$1.28M 0.01%
50,700
-86,000
-63% -$2.07M
SSTI icon
387
SoundThinking
SSTI
$102M
$1.28M 0.01%
+100,000
New +$1.37M
OVV icon
388
Ovintiv
OVV
$16B
$1.27M 0.01%
28,788
-24,246
-46% -$1.26M
SPNC
389
DELISTED
Spectranetics Corp
SPNC
$1.27M 0.01%
+33,000
New +$952K
SYF icon
390
Synchrony
SYF
$25.8B
$1.25M 0.01%
42,069
-2,647,960
-98% -$78.5M
MAC icon
391
Macerich
MAC
$7.2B
$1.23M 0.01%
21,197
-48,664
-70% -$2.95M
RPAI
392
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
$1.22M 0.01%
100,036
-201,898
-67% -$2.65M
WDR
393
DELISTED
Waddell & Reed Financial, Inc.
WDR
$1.17M 0.01%
+61,859
New +$1.09M
STAG icon
394
STAG Industrial
STAG
$7.19B
$1.16M 0.01%
42,053
-1,274
-3% -$34.1K
SVC
395
Service Properties Trust
SVC
$1.02B
$1.15M 0.01%
+7,876
New +$1.2M
CPE
396
DELISTED
Callon Petroleum Company
CPE
$1.14M 0.01%
10,746
-156,360
-94% -$18.3M
BRX icon
397
Brixmor Property Group
BRX
$9.49B
$1.1M 0.01%
61,591
-156,549
-72% -$3.03M
PDCE
398
DELISTED
PDC Energy, Inc.
PDCE
$1.09M 0.01%
25,312
-466,524
-95% -$24.6M
HOUS
399
DELISTED
Anywhere Real Estate
HOUS
$1.09M 0.01%
+33,599
New +$1.02M
NSC icon
400
Norfolk Southern
NSC
$76.8B
$1.09M 0.01%
8,928
-289,276
-97% -$34M
14 15
16
17 18

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $36.1B AUM 19.68% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM

Alyeska Investment Group's Q2 2017 Portfolio in Review

As of Q2 2017, Alyeska Investment Group held 637 positions worth $12B, down 2.9% from $12.3B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Alyeska Investment Group withdrew a net $617M in Q2 2017, closing 191 positions and reducing 150 holdings. Its most notable exit was Eli Lilly, an estimated $133M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Alyeska Investment Group opened a new position in AbbVie worth $128M.

  • Alyeska Investment Group's largest Q2 2017 buy was AbbVie: 1,771,895 shares worth $128M.
  • Alyeska Investment Group added most to Delta Air Lines in Q2 2017, an estimated $140M increase.
  • Alyeska Investment Group's biggest Q2 2017 reduction was Oracle, cutting an estimated $146M.
  • Alyeska Investment Group fully exited Eli Lilly in Q2 2017, selling an estimated $133M.
  • Alyeska Investment Group's ten largest holdings make up 12% of its $12B portfolio in Q2 2017.
  • Alyeska Investment Group opened 171 new positions and closed 191 in Q2 2017.
  • Alyeska Investment Group's portfolio value fell 2.9% quarter-over-quarter to $12B.

Based on Alyeska Investment Group's 13F filing for Q2 2017, filed 14 Aug 2017.